Skip to main content

Low Output Heart Failure: The Cold and Wet Patient

  • Chapter
  • First Online:
Cardiorenal Syndrome in Heart Failure

Abstract

While most patients admitted with congestive heart failure have preserved blood pressure and adequate organ perfusion, an important minority present with low cardiac output and profound organ dysfunction. A careful physical examination can help detect these patients who exhibit signs of volume overload (elevated neck veins, peripheral edema) and impaired cardiac output (narrow pulse pressure, cool or cold extremities). The cold wet patient has significantly increased mortality, even during the hospitalizations because of a cascade of physiologic abnormalities which must be recognized and reversed quickly to avoid multiorgan failure. Worsening renal function is often the first marker of critical illness in the cold wet patient and is one cause of the cardiorenal syndrome. Although low cardiac output may be the cause of a minority of cases of the cardiorenal syndrome, its contribution when present must be recognized and corrected, if possible, to prevent further renal deterioration and patient demise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. H. F. S. of America. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16(6):e1–2.

    Article  Google Scholar 

  2. Nohria A, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41(10):1797–804.

    Article  Google Scholar 

  3. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ, S. G. for the ADHERE Scientific Advisory Committee. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572–80.

    Article  CAS  Google Scholar 

  4. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20(1):248–54.

    Article  CAS  Google Scholar 

  5. Ungar A, et al. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med. 2004;32(5):1125–9.

    Article  CAS  Google Scholar 

  6. Westman L, Järnberg P-O. Effects of dobutamine on haemodynamics and renal function in patients after major vascular surgery. Acta Anaesthesiol Scand. 1987;31(3):253–7.

    Article  CAS  Google Scholar 

  7. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure. Drugs. 1990;39(4):10–21.

    Article  Google Scholar 

  8. Dupont M, Mullens W, Finucan M, Taylor DO, Starling RC, Tang WHW. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail. 2013;15(4):433–40.

    Article  CAS  Google Scholar 

  9. Toma M, Starling RC. Inotropic therapy for end-stage heart failure patients. Curr Treat Options Cardiovasc Med. 2010;12(5):409–19.

    Article  Google Scholar 

  10. Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ Heart Fail. 2009;2(4):320–4.

    Article  CAS  Google Scholar 

  11. Packer M, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106(17):2194–9.

    Article  Google Scholar 

  12. Hjalmarson Å, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). JAMA. 2000;283(10):1295–302.

    Article  CAS  Google Scholar 

  13. Beta-Blocker Evaluation of Survival Trial Investigators, Eichhorn EJ, Domanski MJ, Krause-Steinrauf H, Bristow MR, Lavori PW. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344(22):1659–67.

    Article  Google Scholar 

  14. Mullens W, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589–96.

    Article  Google Scholar 

  15. Firth JD, Raine AEG, Ledingham JGG. Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet. 1988;331(8593):1033–6.

    Article  Google Scholar 

  16. Winton FR. The influence of venous pressure on the isolated mammalian kidney. J Physiol. 1931;72(1):49–61.

    Article  CAS  Google Scholar 

  17. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330(24):1724–30.

    Article  CAS  Google Scholar 

  18. Gruhn N, et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke. 2001;32(11):2530–3.

    Article  CAS  Google Scholar 

  19. Leier CV, Binkley PE. Parenteral inotropic support for advanced congestive heart failure. Prog Cardiovasc Dis. 1998;41(3):207–24.

    Article  CAS  Google Scholar 

  20. Leier CVMD, Heban PTMD, Huss PRN, Bush CAMD, Lewis RPMD. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation. 1978;58(3):466–75.

    Article  CAS  Google Scholar 

  21. Upadya S, et al. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. J Heart Lung Transplant. 2004;23(4):466–72.

    Article  Google Scholar 

  22. Kimura BJ. Point-of-care cardiac ultrasound techniques in the physical examination: better at the bedside. Heart. 2017;103(13):987–94.

    Article  Google Scholar 

  23. Simon MA, Schnatz RG, Romeo JD, Pacella JJ. Bedside ultrasound assessment of jugular venous compliance as a potential point-of-care method to predict acute decompensated heart failure 30-day readmission. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2018;7(15):e008184.

    Google Scholar 

  24. Garibyan VN, Amundson SA, Shaw DJ, Phan JN, Showalter BK, Kimura BJ. Lung ultrasound findings detected during inpatient echocardiography are common and associated with short- and long-term mortality. J Ultrasound Med. 2018;37(7):1641–8.

    Article  Google Scholar 

  25. Meersch M, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551–61.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Thomas Heywood .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Christophy, A., Heywood, J.T. (2020). Low Output Heart Failure: The Cold and Wet Patient. In: Tang, W., Verbrugge, F., Mullens, W. (eds) Cardiorenal Syndrome in Heart Failure. Springer, Cham. https://doi.org/10.1007/978-3-030-21033-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21033-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21032-8

  • Online ISBN: 978-3-030-21033-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics